Next Article in Journal
Platelet-Rich Fibrin in Single and Multiple Coronally Advanced Flap for Type 1 Recession: An Updated Systematic Review and Meta-Analysis
Next Article in Special Issue
Use of an Insulation-Tipped Knife during Rigid Bronchoscopic Treatment of Benign Tracheobronchial Stenosis
Previous Article in Journal
Made in Germany: A Quality Indicator Not Only in the Automobile Industry But Also When It Comes to Skin Replacement: How an Automobile Textile Research Institute Developed a New Skin Substitute
Previous Article in Special Issue
Airway Foreign Body Mimicking an Endobronchial Tumor Presenting with Pneumothorax in an Adult: A Case Report
Article

Effects of Antithrombotic Treatment on Bleeding Complications of EBUS-TBNA

1
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea
2
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea
3
Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea
*
Author to whom correspondence should be addressed.
H.-I.G. and R.-E.K. contributed equally to this work.
Academic Editors: Hae-Seong Nam and Changhwan Kim
Medicina 2021, 57(2), 142; https://doi.org/10.3390/medicina57020142
Received: 11 January 2021 / Revised: 27 January 2021 / Accepted: 1 February 2021 / Published: 5 February 2021
(This article belongs to the Special Issue The Role of Flexible Bronchoscopy in Diagnosing Pulmonary Disease)
Background and Objectives: The application of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has been markedly increased over the past decade. EBUS-TBNA is known to be a very safe and accurate procedure; however, the incidence of bleeding complications in patients who are taking antithrombotic agents (ATAs) is not well established. Materials and Methods: We conducted a retrospective analysis of a prospectively registered EBUS-TBNA cohort in a single tertiary hospital from May 2009 to December 2016. The patients were divided into two groups: an insufficient discontinuation group, defined as having a prescription for ATAs on the procedure day or only interrupting them for a short period of time, and a sufficient discontinuation group, defined as having prescription for ATAs during 30 days prior to the procedure and interrupting them for a sufficient period of time. Results: During the study period, a total of 4271 patients, after excluding 3773 patients who did not take ATAs at all, 498 patients were classified into the insufficient discontinuation group (n = 102) and the sufficient discontinuation group (n = 396). The baseline characteristics of patients and examined lesions between two groups were not significantly different, except insufficient discontinuation group had longer prothrombin times than the sufficient discontinuation group. In the insufficient discontinuation group, the most common reasons for prescriptions of ATAs were ischemic heart disease (48.0%) and cerebral vascular disease (28.4%), and half of the patients were taking two or more ATAs. Eventually, only one bleeding complication in the insufficient discontinuation group (1/102, 1.0%) and one event in the sufficient discontinuation group (1/396, 0.3%) occurred (p = 0.368). Conclusions: EBUS-TBNA is considered a safe procedure in terms of bleeding complications, even in patients with insufficient stopping of ATAs. View Full-Text
Keywords: endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA); antithrombotic agent; antiplatelet drug; anticoagulant agent; bleeding; complication endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA); antithrombotic agent; antiplatelet drug; anticoagulant agent; bleeding; complication
Show Figures

Figure 1

MDPI and ACS Style

Gil, H.-I.; Ko, R.-E.; Lee, K.; Um, S.-W.; Kim, H.; Jeong, B.-H. Effects of Antithrombotic Treatment on Bleeding Complications of EBUS-TBNA. Medicina 2021, 57, 142. https://doi.org/10.3390/medicina57020142

AMA Style

Gil H-I, Ko R-E, Lee K, Um S-W, Kim H, Jeong B-H. Effects of Antithrombotic Treatment on Bleeding Complications of EBUS-TBNA. Medicina. 2021; 57(2):142. https://doi.org/10.3390/medicina57020142

Chicago/Turabian Style

Gil, Hyun-Il, Ryoung-Eun Ko, Kyungjong Lee, Sang-Won Um, Hojoong Kim, and Byeong-Ho Jeong. 2021. "Effects of Antithrombotic Treatment on Bleeding Complications of EBUS-TBNA" Medicina 57, no. 2: 142. https://doi.org/10.3390/medicina57020142

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop